Question

Difficulty: HardMonitoring and Treatment Evaluation

A 2222-year-old woman is brought to the emergency department 22 hours after intentionally ingesting a large, unknown quantity of acetaminophen tablets. She is currently asymptomatic, with normal vital signs and an unremarkable physical examination. Arrange the following steps in the most appropriate chronological sequence for monitoring, evaluating, and managing this patient's overdose according to standard medical protocols.

  1. 1Wait until at least 44 hours have elapsed since ingestion to measure the initial serum acetaminophen concentration.
  2. 2Plot the serum acetaminophen concentration against the time since ingestion on the Rumack-Matthew nomogram.
  3. 3Initiate intravenous NN-acetylcysteine (NAC) therapy if the plotted concentration falls on or above the treatment line.
  4. 4Monitor serial liver aminotransferases, coagulation studies, and serum creatinine to evaluate for evolving hepatotoxicity.
  5. 5Discontinue NN-acetylcysteine therapy once the patient is clinically stable, transaminases are improving, and serum acetaminophen is undetectable.

Answer

The correct sequence is to first wait 44 hours to obtain an interpretable serum level, plot this level on the Rumack-Matthew nomogram, initiate NN-acetylcysteine if the level is above the treatment line, monitor liver chemistries serially during treatment, and finally discontinue the antidote once criteria for resolution are met.
The standard management protocol for acute acetaminophen ingestion requires establishing an accurate peak serum level to guide antidote therapy. Because acetaminophen absorption can be delayed, levels drawn before 44 hours post-ingestion are uninterpretable. Once a valid level is obtained at or after 44 hours, it must be plotted on the Rumack-Matthew nomogram to stratify the patient's risk of hepatotoxicity. If the value falls on or above the treatment line, NN-acetylcysteine (NAC) therapy is initiated to replenish hepatic glutathione stores. While on NAC, the patient requires ongoing monitoring of liver function tests (AST, ALT), coagulation (PT/INR), and renal function to evaluate for subacute hepatic injury. Finally, the treatment is evaluated for discontinuation; NAC can be safely stopped only when the patient is asymptomatic, liver enzymes are normalizing, and the serum acetaminophen level is undetectable.

Step-by-Step Solution

1
Delay initial serum level until 44 hours post-ingestion
Obtains an accurate reflection of peak absorption
Levels drawn before 44 hours are uninterpretable on the nomogram due to ongoing drug absorption.
2
Plot level on the Rumack-Matthew nomogram
Risk stratification for hepatotoxicity
Determines if the patient's toxic burden warrants antidote therapy.
3
Initiate NN-acetylcysteine (NAC)
Prevents accumulation of the toxic NAPQI metabolite
Provides a glutathione substitute to detoxify the liver if the nomogram indicates high risk.
4
Monitor serial LFTs and coagulation studies
Tracks the evolution of hepatic injury
Detects subacute hepatotoxicity that may develop despite NAC and guides ongoing treatment.
5
Discontinue NAC based on clinical and laboratory criteria
Safe conclusion of therapy
Ensures the toxic threat has completely resolved (undetectable acetaminophen and improving LFTs) before stopping the antidote.

Key Concept

Monitoring and evaluating treatment in acute acetaminophen overdose relies on delaying initial levels until peak absorption at 44 hours, using the Rumack-Matthew nomogram for risk stratification, and guiding the discontinuation of NN-acetylcysteine with serial liver function monitoring.
Estimated Time:1m 30s
Rate this question